Cafepharma Today

April 1 2025 - Biopharmas laid off staffers at least 63 times in Q1: Fierce Biotech analysis
Biopharmas laid off staffers at least 63 times in Q1: Fierce Biotech analysis
Widespread job cuts begin at health agencies
FTC concerned about privacy protections in 23andMe bankruptcy
Bausch + Lomb recalls Envista intraocular lenses over safety risks
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Biopharmas laid off staffers at least 63 times in Q1: Fierce Biotech analysis
Fierce Biotech
Tuesday, April 1, 2025 - 11:46am
tags:
layoffs, biotech, cell therapy, gene therapy
Widespread job cuts begin at health agencies
NBC News
Tuesday, April 1, 2025 - 11:44am
tags:
HHS, layoffs, Donald Trump
Pharma industry lobbies Trump for phased tariffs, sources say
MSN/Reuters
Tuesday, April 1, 2025 - 11:40am
tags:
lobbying, Donald Trump, pharma industry, tariffs, phased tariffs
Pfizer, Flagship tap Valo Health for autoimmune offshoot of multibillion-dollar collab
Fierce Biotech
Tuesday, April 1, 2025 - 11:39am
tags:
Pfizer, Flagship Pioneering, autoimmmune disease, Valo Health
Vaxcyte stock sinks despite Phase II IPD vaccine trial success
Clinical Trials Arena
Tuesday, April 1, 2025 - 11:38am
tags:
Vaxcyte, pneumococcal disease, vaccines, clinical trials
FTC concerned about privacy protections in 23andMe bankruptcy
Yahoo/Reuters
Tuesday, April 1, 2025 - 11:37am
tags:
23andMe, diagnostics, FDC, data, bankruptcy
Merck Group pays $85M to nab global rights for Abbisko's rare tumor drug after phase 3 win
Fierce Biotech
Tuesday, April 1, 2025 - 11:36am
tags:
Merck KGaA, pimicotinib, Abbisko Therapeutics
ACC 25: Biocardia’s CardiAMP trial fails but cell therapy potential remains
Clinical Trials Arena
Tuesday, April 1, 2025 - 11:34am
tags:
BioCardia, CardiAMP, cell therapy, heart failure with reduced ejection fraction, ACC
AIRNA nets $155M series B to launch clinical test of RNA editing tech
Fierce Biotech
Tuesday, April 1, 2025 - 11:34am
tags:
AIRNA, funding, RNA editing
Bausch + Lomb recalls Envista intraocular lenses over safety risks
Medtech Dive
Tuesday, April 1, 2025 - 11:30am
tags:
Medtech, Bausch + Lomb, Envista, intraocular lenses, device recall
With government health info in limbo, drugmakers lose credible sources
Pharma Voice
Tuesday, April 1, 2025 - 11:27am
tags:
pharma industry, data, clinical trials
EVERSANA joins with Veeva in push to 'pharmatise AI'
Pharmaphorum
Tuesday, April 1, 2025 - 11:26am
tags:
Eversana, Veeva, artificial intelligence
Medtronic Breaks Out Strong TAVR Data at ACC
Medical Devices and Diagnostics Industry
Monday, March 31, 2025 - 11:06pm
tags:
Medtech, Medtronic, TAVR, ACC, Evolut
J&J Plan for Bankruptcy to End Talc Cancer Claims Rejected
MSN/Reuters
Monday, March 31, 2025 - 11:04pm
tags:
JNJ, legal, bankruptcy
AstraZeneca bulks up Imfinzi's prowess with FDA nod in bladder cancer around surgery
Fierce Pharma
Monday, March 31, 2025 - 11:01pm
tags:
AstraZeneca, Imfinzi, muscle-invasive bladder cancer
Boston Scientific's Acquisition Target Strikes Lightning-Fast FDA Clearance
Medical Devices and Diagnostics Industry
Monday, March 31, 2025 - 10:59pm
tags:
Medtech, Boston Scientific, Bolt Medical, intravascular lithotripsy
Recruiting trials dominated in 2024
Clinical Trials Arena
Monday, March 31, 2025 - 10:57pm
tags:
clinical trials, clinical trial recruitment
Transcend’s PTSD therapy shows potential in Phase II trial
Clinical Trials Arena
Monday, March 31, 2025 - 10:56pm
tags:
Transcend Therapeutics, PTSD, TSND-201
Pharma stocks sink after ouster of top FDA vaccine regulator
MSN/Reuters
Monday, March 31, 2025 - 11:05am
tags:
pharma stocks, FDA, Peter Marks, Robert F Kennedy Jr.
Merck's Winrevair slashes mortality-morbidity risk by 76%
Fierce Pharma
Monday, March 31, 2025 - 11:02am
tags:
Merck, PAH, Winrevair, clinical trials

Pages

Latest CP Wire Articles

The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform

Latest Pharmagather Articles

A New Pan-Coronovirus Protease Inhibitor Possibility
In the Pipeline
Pain Continues to Be a Pain
In the Pipeline
Alkanes on Mars
In the Pipeline
Starving Cancer Cells Where They Live
In the Pipeline
Informa Connect’s Life Sciences Pricing & Contracting USA
Drug Channels
Evolving the Ability to Evolve
In the Pipeline
Metamorphine, An Unwelcome Product
In the Pipeline
The End of the Blockbuster Era: Unlocking Growth with Direct-to-Patient Commercialization
Drug Channels
A New Type of Antifungal
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.